BioRestorative Therapies, Inc. ("BioRestorative,” "BRTX” or the "Company”) (NASDAQ: BRTX), a clinical-stage regenerative me ...

Glioblastoma (GBM) is the most aggressive and lethal form of brain cancer, with a median survival of only 15 months despite ...

Bioprinted epiblast-like structures mimic early human embryonic development, offering a scalable, ethical platform to study ...

Over 500 million people worldwide suffer from diabetes—a disease that contributes to major complications such as stroke, ...

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...

Find more information on the Altmetric Attention Score and how the score is calculated. Mesenchymal stem cells (MSCs) are of interest in regenerative medicine owing to their multilineage ...

Mesenchymal stem/stromal cells (MSCs) are multipotent cells distributed in all tissues and characterized by adherence, morphology, immunophenotype and trilineage differentiation potential. The present ...

It is highly expressed in glioblastoma multiforme, the most aggressive brain tumor in adults, and in its stem cells [glioblastoma stem cells (GSCs)], which contribute to treatment resistance and tumor ...

Once in the bone marrow, P-SSCs are phenotypically and functionally reprogrammed into bone marrow mesenchymal stem cells (BM-MSCs) that express high levels of hematopoietic stem cell niche factors ...

Stem cells from donated placentas appear safe and may help reduce symptoms of secondary progressive multiple sclerosis (MS), according to a small, open-label Phase 1 clinical trial involving five ...